Sefitaz 2250mg Injection
Marketer
Dote Health Care
Salt Composition
Cefepime (2000mg) + Tazobactum (250mg)
Overview Sefitaz 2250mg Injection
Ceftazidime/Sulbactam 2250mg injection is a dual-antibiotic therapy indicated for diverse bacterial infections. Its mechanism involves inhibiting microbial growth. Administration must be solely by a healthcare provider. Consistent adherence to the prescribed dosage schedule is crucial, completing the entire course regardless of symptom improvement. Common adverse reactions include nausea, vomiting, diarrhea, and skin rashes. Local injection site reactions like redness, swelling, and pain may occur but typically resolve. Worsening side effects require immediate medical attention. Seek emergency care for allergic reactions (e.g., hives, itching, swelling, respiratory distress). Prior to use, disclose all current medications and pre-existing conditions to your physician. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs.
Uses of Sefitaz 2250mg Injection
Infections caused by bacteria
Major Benefits of Sefitaz 2250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Sefitaz 2250mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Sefitaz 2250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Sefitaz 2250mg Injection works:
Sefitaz 2250mg Injection unites Cefepime, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum counteracts bacterial enzymes that would otherwise neutralize Cefepime, thus broadening Cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Sefitaz 2250mg Injection concurrently with alcohol. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Sefitaz, 2250mg, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, clinical data from human subjects are scarce.
Breast feedingSAFE IF PRESCRIBED
Use of Sefitaz 2250mg Injection while breastfeeding is considered safe. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
Following administration of Sefitaz 2250mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
Patients with impaired kidney function require careful monitoring when administered Sefitaz 2250mg Injection. Dosage modification for Sefitaz 2250mg Injection might be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
Ceftazidime 2250mg injection appears safe for individuals with hepatic impairment. Preliminary evidence indicates dose modification may not be necessary. Physician consultation is recommended.
What if you forget to take Sefitaz 2250mg Injection :
Omit a dose of Sefitaz 2250mg Injection? Seek medical advice immediately.
Facts to Know About Sefitaz 2250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
3,018 People bought this recently